市場調查報告書
商品編碼
1390658
人類增強市場:2023-2028 年全球產業趨勢、佔有率、規模、成長、機會與預測Human Enhancement Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 |
2022年,全球人類增強市場規模達到979億美元。展望未來, IMARC Group預計到2028年市場規模將達到2,159億美元,2022-2028年複合年成長率(CAGR)為14.09%。
人類增強是指對身體進行自然的、人工的和技術的改變,以增強個體的認知和身體能力和功能。它透過藥物、荷爾蒙、植入物、基因工程、膳食補充劑和整容手術來進行自我完善。如今,人類增強技術的進步提供了對瘧疾、結核病和萊姆病等疾病的抵抗力。它們還允許最新的診斷和基因組編輯技術的進步,例如用於人類免疫缺陷病毒(HIV)感染的功能性治癒的成簇規則間隔短回文重複序列(CRISPR)。
急性和慢性疾病的日益流行,以及醫療保健服務的日益普及,是積極影響全球人類增強技術需求的關鍵因素之一。這些技術主要包括奈米技術、資訊科技(IT)和認知科學,有助於升級生物醫學介入措施以及診斷和治療各種疾病。它們還包括主動控制系統,有助於創造具有超越人類表現特徵的肢體義肢。此外,基因工程、神經元植入、腦機介面和3D(3D)生物列印等新興技術也促進了市場的成長。除此之外,由於國家之間地緣政治緊張局勢加劇,一些國家的安全機構正在投資研究項目,以提高戰場表現。例如,法國陸軍的倫理委員會批准了用於培養增強型士兵的人體增強技術的研究。這項研究還涉及利用從藥物到外骨骼等先進系統來增強軍事人員的目標決策能力。預計這些因素將推動人類增強技術的採用,並對未來幾年的市場產生積極影響。
The global human enhancement market size reached US$ 97.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 215.9 Billion by 2028, exhibiting a growth rate (CAGR) of 14.09% during 2022-2028.
Human enhancement refers to a natural, artificial, and technological alteration of the body to enhance cognitive and physical capabilities and functions of individuals. It is undertaken using drugs, hormones, implants, genetic engineering to dietary supplements and cosmetic surgeries for self-improvement. Nowadays, advances in human enhancement technologies provide resistance against diseases like malaria, tuberculosis, and Lyme. They also allow up-to-date diagnostic and advancements in genome editing technologies, such as clustered regularly interspaced short palindromic repeats (CRISPR) for a functional cure of human immunodeficiency virus (HIV) infection.
The growing prevalence of acute and chronic diseases, in confluence with the increasing access to healthcare services, represents one of the key factors positively influencing the demand for human enhancement technologies around the world. These technologies mainly include nanotechnology, information technology (IT), and cognitive science, which assist in upgrading biomedical interventions as well as diagnose and treat various diseases. They also comprise active control systems that help create limb prosthetics with characteristics that exceed human performance. Moreover, emerging technologies like genetic engineering, neuronal implants, brain-computer interfaces, and three-dimensional (3D) bioprinting are contributing to the market growth. Apart from this, due to rising geopolitical tension between countries, security agencies of several countries are investing in research programs to improve battlefield performance. For instance, the ethics committee in the French Army approved the research of human enhancement technologies for developing enhanced soldiers. This research also involves the utilization of advanced systems, ranging from drugs to exoskeletons, to enhance military personnel in targeting decisions. These factors are anticipated to drive the adoption of human enhancement technologies and influence the market positively in the coming years.
IMARC Group provides an analysis of the key trends in each sub-segment of the global human enhancement market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, device type and end user.
Exoskeleton
Smart Devices
Medical Devices
Implants
Others
Body Worn
Non-Body Worn
Healthcare
Defense
Information Technology
Others
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being BrainGate, B-Temia Inc, Ekso Bionics, Google LLC, Magic Leap Inc, Raytheon Technologies Corporation, ReWalk Robotics Ltd, Samsung Electronics Co. Ltd., Second Sight Medical Products Inc. and Vuzix Corporation.